enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Alexion Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Alexion_Pharmaceuticals

   Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.

3. AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/AstraZeneca

   The AstraZeneca R&D facility in Mölndal near Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, United Kingdom AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology , cardiovascular , gastrointestinal , infection , neuroscience , respiratory ...

4. AstraZeneca to Establish Strategic R&D Center in ... - AOL

   www.aol.com/2013/03/18/astrazeneca-to-establish...

   The consolidation of AstraZeneca's global R&D footprint will have an impact on sites in the United States. About 1,200 positions will leave Wilmington, while there will be an increase of about 300 ...

5. List of technology centers - Wikipedia

   en.wikipedia.org/wiki/List_of_technology_centers

   How much and to what extent public and/or private research and development (R&D) funds are spent in the zones; What percentage of local employment is technology related; If the zone is mainly government funded or is mainly corporate driven (or is it a mix of both)

6. Fortrea - Wikipedia

   en.wikipedia.org/wiki/Fortrea

   Fortrea Holdings Inc. is a contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries.

7. Cambridge Antibody Technology - Wikipedia

   en.wikipedia.org/wiki/Cambridge_Antibody_Technology

   [3] [4] AstraZeneca subsequently acquired MedImmune LLC, [5] which it combined with CAT to form a global biologics R&D division called MedImmune. [6] CAT was often described as the 'jewel in the crown' of the British biotechnology industry [ 7 ] and during the latter years of its existence was the subject of frequent acquisition speculation.

8. Merck & Co. - Wikipedia

   en.wikipedia.org/wiki/Merck_&_Co.

   The case came to a head when a research scientist believed he was communicating with Merck & Co regarding a research grant in oncology, when in fact he was talking with the Merck Group. As a result, Merck & Co. asked the federal court to stop the Merck Group from using "Merck" on any products or marketing materials in the United States.

9. MD Anderson Cancer Center - Wikipedia

   en.wikipedia.org/wiki/MD_Anderson_Cancer_Center

   The MD Anderson Cancer Center's Africa Initiative, part of its Global Oncology Program launched in September 2022, aims to reduce the cancer burden in low- and middle-income countries (LMICs) through comprehensive education, training, and collaborative research. One of the flagship projects under this initiative is Project ECHO (Extension for ...